statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ArriVent BioPharma (NASDAQ:AVBP) Sees Unusually-High Trading Volume

ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 190,786 shares changed hands during mid-day trading, a decline of 12% from the...

ArriVent BioPharma Reports Full Year 2023 Financial Results

Company progresses the development of furmonertinib with a data readout planned for 2024Furmonertinib granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration Completed $201...

ArriVent BioPharma, Inc.'s (NASDAQ:AVBP) Quiet Period Will End  on March 6th

ArriVent BioPharmas (NASDAQ:AVBP  Get Free Report) quiet period is set to expire on Wednesday, March 6th. ArriVent BioPharma had issued 9,722,222 shares in its IPO on January 26th. The...

ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated by Analysts at The Goldman Sachs Group

The Goldman Sachs Group assumed coverage on shares of ArriVent BioPharma (NASDAQ:AVBP  Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The...

ArriVent Announces Pricing of Upsized Initial Public Offering

NEWTOWN SQUARE, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. ( ArriVent ) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative...

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Volume	75,165.00
52-Wk High	$25.95
52-Wk Low	$14.35

AVBP ArriVent BioPharma Inc.

About

Feed

News

Sentiment

Fundamentals